Home › Ventricular Tachycardia › NCT05599022
Randomized Assessment of TcMS for VT Storm
Randomized Assessment of the Efficacy of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * ≥3 episodes of sustained VT or appropriate ICD therapies within 24 hours despite the use of at least one antiarrhythmic drug Exclusion Criteria: * Plan for catheter ablation of VT in the next 24 hours * Pregnancy * Contraindication to TcMS (i.e. implantable ventricular assist device, metal implanted in the head or neck \[except the mouth\], implanted medication pumps, cochlear implant, implanted brain stimulator, ocular implant, history of malignancy in the neck)
About the study
Three-arm randomized clinical trial comparing two strategies of TcMS to sham stimulation in patients with VT storm. The hypothesis of the study is that TcMS will reduce the burden of VT in the 24 hours after randomization compared to sham stimulation and that TcMS with theta burst stimulation (TBS) will be more effective at reducing VT burden than low frequency TcMS.
What is being tested
- Magnetic Stimulation (device)
Sponsor: University of Pennsylvania · Participants: 60 · Started: May 22, 2023
Contact the study team
- Timothy Markman · Phone: 215-615-4332
Official record on ClinicalTrials.gov — NCT05599022
Locations in the U.S.
| Pennsylvania | Hospital of the University of Pennsylvania, Philadelphia |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.